Rubio, Jilianne R.

HRN: 29-17-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2026
CEFUROXIME 750MG (VIAL)
06/20/2026
06/26/2026
IV
750 Mg
Q8H
Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: